Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CLGN

CollPlant Biotechnologies Ltd.

Healthcare · USD

Set alert

Price alert · CLGN

All alert types
4.14 USD -0.27 -6.02%
As of Oct 30, 2026 Extended hours 4.10 -0.85%
Bid
4.10 × 1
Ask
4.20 × 1
4.10 Day range 4.60
2.73 52-week range 22.80
YTD
-70.46%
1 year
-81.12%
Open
4.20
Prev close
4.40
Mkt cap
11.91M
Vol
44.25K
Avg vol
365.75K
EPS
-9.33
P/E
0.00
Div yield
0.00%
More statistics
Low
4.10
High
4.60
Forward P/E
-8.82
Beta
0.48
Short ratio
0.70
Inst. own
12.23%
Dividend
0.00
Ex-div date
Earnings
Aug 20, 2024
50-d avg
4.04
200-d avg
4.90
1y target
12.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CLGN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-29.70 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.5×
FY 2016: -2.5×FY 2017: -4.0×FY 2018: -2.9×FY 2019: -1.9×FY 2020: -12.8×FY 2021: 399×FY 2022: -5.5×FY 2023: -10.3×FY 2024: -2.5×FY 2025: -1.5×
FY 2016 5y median -2.5× FY 2025
P/S 7.2×
FY 2016: 239×FY 2017: 50.0×FY 2018: 3.8×FY 2019: 12.3×FY 2020: 12.1×FY 2021: 10.4×FY 2022: 308×FY 2023: 6.6×FY 2024: 80.1×FY 2025: 7.2×
FY 2016 5y median 10.4× FY 2025
P/B 2.8×
FY 2016: 13.5×FY 2017: 9.2×FY 2018: 3.9×FY 2019: 7.0×FY 2020: 16.6×FY 2021: 3.6×FY 2022: 2.9×FY 2023: 2.6×FY 2024: 3.1×FY 2025: 2.8×
FY 2016 5y median 2.9× FY 2025
P/FCF -1.8×
FY 2016: -3.5×FY 2017: -4.7×FY 2018: -9.0×FY 2019: -4.0×FY 2020: -15.2×FY 2021: 152×FY 2022: -6.2×FY 2023: -19.6×FY 2024: -2.8×FY 2025: -1.8×
FY 2016 5y median -2.8× FY 2025
EV/EBITDA -1.3×
FY 2016: -2.4×FY 2017: -4.1×FY 2018: -2.2×FY 2019: -2.7×FY 2020: -14.6×FY 2021: 147×FY 2022: -4.1×FY 2023: -8.3×FY 2024: -2.1×FY 2025: -1.3×
FY 2016 5y median -2.1× FY 2025
EV/Sales 5.9×
FY 2016: 226×FY 2017: 46.8×FY 2018: 2.7×FY 2019: 12.2×FY 2020: 12.1×FY 2021: 9.8×FY 2022: 219×FY 2023: 4.5×FY 2024: 62.9×FY 2025: 5.9×
FY 2016 5y median 9.8× FY 2025
FCF Yield -55.3%
FY 2016: -28.4%FY 2017: -21.2%FY 2018: -11.1%FY 2019: -25.3%FY 2020: -6.6%FY 2021: 0.7%FY 2022: -16.3%FY 2023: -5.1%FY 2024: -35.3%FY 2025: -55.3%
FY 2016 5y median -16.3% FY 2025

Profitability

Gross Margin 26.3%
FY 2016: -196.3%FY 2017: 32.8%FY 2018: 65.0%FY 2019: 18.9%FY 2020: 43.7%FY 2021: 87.2%FY 2022: -393.6%FY 2023: 71.8%FY 2024: -417.1%FY 2025: 26.3%
FY 2016 5y median 26.3% FY 2025
Operating Margin -484.3%
FY 2016: -9433.2%FY 2017: -1244.2%FY 2018: -84.9%FY 2019: -329.2%FY 2020: -91.2%FY 2021: 0.4%FY 2022: -5718.1%FY 2023: -68.5%FY 2024: -3349.7%FY 2025: -484.3%
FY 2016 5y median -484.3% FY 2025
Net Margin -484.6%
FY 2016: -9571.9%FY 2017: -1209.6%FY 2018: -130.5%FY 2019: -481.6%FY 2020: -94.1%FY 2021: 1.5%FY 2022: -5660.5%FY 2023: -64.0%FY 2024: -3225.0%FY 2025: -484.6%
FY 2016 5y median -484.6% FY 2025
ROE -188.9%
FY 2016: -541.7%FY 2017: -222.1%FY 2018: -131.3%FY 2019: -273.1%FY 2020: -129.0%FY 2021: 0.5%FY 2022: -52.4%FY 2023: -24.8%FY 2024: -123.3%FY 2025: -188.9%
FY 2016 5y median -52.4% FY 2025
ROIC -128.6%
FY 2016: -361.2%FY 2017: -89.7%FY 2018: -59.5%FY 2019: -98.2%FY 2020: -70.9%FY 2021: 0.1%FY 2022: -48.6%FY 2023: -23.8%FY 2024: -104.3%FY 2025: -128.6%
FY 2016 5y median -48.6% FY 2025
ROA -106.5%
FY 2016: -193.7%FY 2017: -71.9%FY 2018: -69.1%FY 2019: -103.8%FY 2020: -53.3%FY 2021: 0.5%FY 2022: -44.8%FY 2023: -20.6%FY 2024: -88.8%FY 2025: -106.5%
FY 2016 5y median -44.8% FY 2025

Growth (YoY)

Revenue 360.4%
FY 2016: 0.0%FY 2017: 532.2%FY 2018: 897.8%FY 2019: -51.6%FY 2020: 164.8%FY 2021: 154.9%FY 2022: -98.1%FY 2023: 3565.2%FY 2024: -95.3%FY 2025: 360.4%
FY 2016 FY 2025
Operating Income 33.4%
FY 2016: -48.6%FY 2017: 16.6%FY 2018: 31.9%FY 2019: -87.7%FY 2020: 26.6%FY 2021: 101.2%FY 2022: -26403.1%FY 2023: 56.1%FY 2024: -129.6%FY 2025: 33.4%
FY 2016 FY 2025
EPS (diluted) 35.2%
FY 2016: -27.2%FY 2017: 36.9%FY 2018: 37.0%FY 2019: -106.3%FY 2020: 71.5%FY 2021: 104.1%FY 2022: -4544.4%FY 2023: 59.2%FY 2024: -133.9%FY 2025: 35.2%
FY 2016 FY 2025
Free Cash Flow 35.2%
FY 2016: -26.4%FY 2017: 1.1%FY 2018: 59.8%FY 2019: -251.1%FY 2020: 32.1%FY 2021: 122.0%FY 2022: -1495.3%FY 2023: 75.2%FY 2024: -292.1%FY 2025: 35.2%
FY 2016 FY 2025

Financial Health

Current Ratio 2.5×
FY 2016: 1.2×FY 2017: 4.6×FY 2018: 3.2×FY 2019: 1.5×FY 2020: 1.7×FY 2021: 15.0×FY 2022: 10.2×FY 2023: 8.6×FY 2024: 4.4×FY 2025: 2.5×
FY 2016 5y median 8.6× FY 2025
Quick Ratio 2.3×
FY 2016: 1.1×FY 2017: 4.4×FY 2018: 2.8×FY 2019: 1.2×FY 2020: 1.3×FY 2021: 14.6×FY 2022: 9.7×FY 2023: 8.4×FY 2024: 4.3×FY 2025: 2.3×
FY 2016 5y median 8.4× FY 2025
Debt / Equity 0.5×
FY 2016: 0.0×FY 2017: 1.4×FY 2018: 0.0×FY 2019: 0.9×FY 2020: 0.8×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.5×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.3×
FY 2016: 0.1×FY 2017: 0.3×FY 2018: 0.9×FY 2019: 0.0×FY 2020: -0.0×FY 2021: -9.1×FY 2022: 1.7×FY 2023: 4.0×FY 2024: 0.6×FY 2025: 0.3×
FY 2016 5y median 0.6× FY 2025
Interest Coverage -766×
FY 2016: -451×FY 2017: -56.5×FY 2018: -156×FY 2019: -105×FY 2020: -165×FY 2021: 1.8×FY 2022: -503×FY 2023: -751×FY 2024: -1015×FY 2025: -766×
FY 2016 5y median -751× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31